All‐cause mortality associated with atypical and typical antipsychotics in demented outpatients
- 12 October 2006
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 16 (5), 538-544
- https://doi.org/10.1002/pds.1334
Abstract
Purpose To estimate the association between use of typical and atypical antipsychotics and all-cause mortality in a population of demented outpatients. Methods The study cohort comprised all demented patients older than 65 years and registered in the Integrated Primary Care Information (IPCI) database, during 1996–2004. First, mortality rates were calculated during use of atypical and typical antipsychotics. Second, we assessed the association between use of atypical and typical antipsychotics and all-cause mortality through a nested case-control study in the cohort of demented patients. Each case was matched to all eligible controls at the date of death by age and duration of dementia. Odds ratios were estimated through conditional logistic regression analyses. Results The crude mortality rate was 30.1 (95%CI: 18.2–47.1) and 25.2 (21.0–29.8) per 100 person-years (PY) during use of atypical and typical antipsychotics, respectively. No significant difference in risk of death was observed between current users of atypical and typical antipsychotics (OR = 1.3; 95%CI: 0.7–2.4). Both types of antipsychotics were associated with a significantly increased risk of death as compared to non-users (OR = 2.2, 1.2–3.9 for atypical antipsychotics; OR=1.7, 1.3–2.2 for typical antipsychotics). Conclusions Conventional antipsychotic drug should be included in the FDA's Public Health advisory, which currently warns only of the increased risk of death with the use of atypical antipsychotics in elderly demented persons. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort studyBMJ, 2005
- Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trialsCMAJ : Canadian Medical Association Journal, 2004
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year StudiesAmerican Journal of Psychiatry, 2004
- The incidence of sudden cardiac death in the general populationJournal of Clinical Epidemiology, 2004
- Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homesInternational Journal of Geriatric Psychiatry, 2004
- International Primary Care Classifications: the Effect of Fifteen Years of EvolutionFamily Practice, 1992
- Modeling and variable selection in epidemiologic analysis.American Journal of Public Health, 1989